dup 734 has been researched along with enkephalin-leu, ala(2)-arg(6)- in 1 studies
Studies (dup 734) | Trials (dup 734) | Recent Studies (post-2010) (dup 734) | Studies (enkephalin-leu, ala(2)-arg(6)-) | Trials (enkephalin-leu, ala(2)-arg(6)-) | Recent Studies (post-2010) (enkephalin-leu, ala(2)-arg(6)-) |
---|---|---|---|---|---|
25 | 0 | 0 | 332 | 22 | 11 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maslov, LN; Naryzhnaya, NV; Tam, SW | 1 |
1 other study(ies) available for dup 734 and enkephalin-leu, ala(2)-arg(6)-
Article | Year |
---|---|
Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress.
Topics: Animals; Anti-Arrhythmia Agents; beta-Endorphin; Disease Models, Animal; Dynorphins; Enkephalin, Leucine-2-Alanine; Heart; Immobilization; Ligands; Morphine; Myocardial Infarction; Myocardium; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Piperidines; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, delta; Stress, Physiological; Ventricular Fibrillation | 1999 |